The Valley Desk

NCT02066415 · Interventional trial

A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention

Overall registry status Completed

Phase 2

Conditions Treatment for Prevention of Chronic Migraine

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov